Eileen M. O'Reilly, MD

Associate Director for Clinical Research
David M. Rubenstein Center for Pancreas Cancer
Memorial Sloan-Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York

Dr. Eileen M. O’Reilly received her medical degree at Trinity College (Dublin University) in her native Ireland. She completed her residency training in Ireland and her fellowship training at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. Dr. O’Reilly serves as the associate director for clinical research at the David M. Rubenstein Center for Pancreas Cancer at MSKCC, where she is also an attending physician. In addition, Dr. O’Reilly is professor of medicine at Weill Cornell Medical College.

Nationally, Dr. O’Reilly is the chair of the Alliance Co-operative Group Gastrointestinal Cancers Committee, and serves on the Scientific Advisory Board of the Pancreatic Cancer Action Network, NCCN Pancreas panel, and is on the board of the National Pancreas Foundation and ASCO IMT committee. Her institutional responsibilities include associate chairpersonship of the MSKCC Institutional Review & Privacy Board (IRB), membership of Research Council, and chair of the Continuing Medical Education (CME) committee.

Dr. O’Reilly is the Principal Investigator of multiple phase I, II and III trials in pancreas cancer and has authored/co-authored multiple articles, editorials and book chapters. Her major research focus and clinical activities include pancreatic and hepatobiliary malignancies, and her research initiatives include integration of molecular and genetic-based therapies for the treatment of pancreas cancer, along with development of adjuvant and neoadjuvant therapies and identification of biomarkers that may be used to select therapy. In addition, Dr. O’Reilly teaches and mentors oncology fellows, junior faculty, residents and house-staff, and has won numerous teaching and other awards.

Last modified: July 18, 2017